RxDoctor Payments Data

Megan Welker, DO

Family Medicine · Muncie, INNPI 1396196556

Payments from drug & device makers

$8,041in general payments, 2019–2025

Across 522 payments — averaging $15.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$652
  • Amgen$621
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$582
  • Bayer$474
  • AstraZeneca$344
  • plus $3K from 43 others

What the payments were for

  • Food & beverage$8,041100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,041 in reported general payments places this provider in the 90th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$1,872
Medicare patients
24
Services billed
50

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin67$63,431
TrulicityDulaglutide45$58,499
OzempicSemaglutide33$34,960
MounjaroTirzepatide25$33,656
LinzessLinaclotide23$25,957
JanuviaSitagliptin Phosphate24$18,389
EliquisApixaban12$14,109
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$11,674
XareltoRivaroxaban21$11,552
Nurtec OdtRimegepant Sulfate11$11,365
KerendiaFinerenone12$11,310
InvokanaCanagliflozin14$9,599
Breo ElliptaFluticasone/Vilanterol13$7,552
DexilantDexlansoprazole15$6,771
TrintellixVortioxetine Hydrobromide11$6,002

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$652$92,15570 claims
Boehringer IngelheimJardiance$82$63,43167 claims
Novo NordiskOzempic$269$34,96033 claims
AbbVieLinzess$1,901$25,95723 claims
PfizerEliquis, Nurtec Odt$140$25,47423 claims
MerckJanuvia$17$18,38924 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant, Trintellix$284$12,77326 claims
AstraZenecaBreztri Aerosphere$344$11,67414 claims
GSKBreo Ellipta, Arnuity Ellipta$15$11,42926 claims
BayerKerendia$474$11,31012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Muncie

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →